首页> 外文期刊>Biomacromolecules >Long Hydrophilic-and-Cationic Polymers: A Different Pathway toward Preferential Activity against Bacterial over Mammalian Membranes
【24h】

Long Hydrophilic-and-Cationic Polymers: A Different Pathway toward Preferential Activity against Bacterial over Mammalian Membranes

机译:长的亲水性和阳离子性聚合物:哺乳动物膜上对细菌的优先活性的不同途径

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

We show that simply converting the hydrophobic moiety of an antimicrobial peptide (AMP) or synthetic mimic of AMPs (SMAMP) into a hydrophilic one could be a different pathway toward membrane-active antimicrobials preferentially acting against bacteria over host cells. Our biostatistical analysis on natural AMPs indicated that shorter AMPs tend to be more hydrophobic, and the hydrophilic-and-cationic mutants of a long AMP experimentally demonstrated certain membrane activity against bacteria. To isolate the effects of antimicrobials' hydrophobicity and systematically examine whether hydrophilic-and-cationic mutants could inherit the membrane activity of their parent AMPs/SMAMPs, we constructed a minimal prototypical system based on methacrylate-based polymer SMAMPs and compared the antibacterial membrane activity and hemolytic toxicity of analogues with and without the hydrophobic moiety. Antibacterial assays showed that the hydrophobic moiety of polymer SMAMPs consistently promoted the antibacterial activity but diminished in effectiveness for long polymers, and the resultant long hydrophilic-and-cationic polymers were also membrane active against bacteria. What distinguished these long mutants from their parent SMAMPs were their drastically reduced hemolytic toxicities and, as a result, strikingly enhanced selectivity. Similar toxicity reduction was observed with the hydrophilic-and-cationic mutants of long AMPs. Taken together, our results suggest that long hydrophilic-and-cationic polymers could offer preferential membrane activity against bacteria over host cells, which may have implications in future antimicrobial development.
机译:我们表明,简单地将抗菌肽(AMP)的疏水部分或AMPs(SMAMP)的合成模拟物转换成亲水的一种,可能是通向膜活性抗菌剂的另一种途径,该抗菌剂优先于细菌而不是宿主细胞。我们对天然AMP的生物统计分析表明,较短的AMP倾向于更疏水,长AMP的亲水和阳离子突变体实验证明对细菌具有一定的膜活性。为了隔离抗菌剂疏水性的影响并系统地检查亲水和阳离子突变体是否可以继承其亲代AMP / SMAMP的膜活性,我们基于甲基丙烯酸酯基聚合物SMAMP构建了一个最小的原型系统,并比较了其抗菌膜活性和具有和不具有疏水部分的类似物的溶血毒性。抗菌分析表明,聚合物SMAMPs的疏水部分始终提高抗菌活性,但对长聚合物的有效性却有所降低,并且所得的长亲水和阳离子聚合物对细菌也具有膜活性。这些长突变体与其亲代SMAMP的不同之处在于,它们的溶血毒性大大降低,因此,其选择性显着提高。用长AMP的亲水和阳离子突变体观察到相似的毒性降低。两者合计,我们的结果表明,长的亲水性和阳离子性聚合物可以提供比宿主细胞更优先的针对细菌的膜活性,这可能对未来的抗菌药物开发产生影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号